Global Autotransfusion Devices Market Forecast to 2028: Technological Developments & Elevated Healthcare Expenditure in Emerging Economies Presents Opportunities –

DUBLIN–(BUSINESS WIRE)–The “Autotransfusion Devices Market Forecast to 2028- COVID-19 Impact and Global Analysis – by Type; Application; End User” report has been added to’s offering.

Accessories Segment to Hold Largest Share of Autotransfusion Devices Market During 2021-2028

Global autotransfusion devices market size is expected to grow from US$ 1,000.26 million in 2021 to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028.

The rapid increase in chronic diseases, rise in transplants, and difficulty in obtaining blood groups across the globe are contributing to the autotransfusion devices market growth.

The rapid spread of the COVID-19 pandemic has provided significant momentum to the autotransfusion device industry in 2020. SARS-CoV-2 (also known as COVID-19) has presented an unprecedented difficulty in several areas of medicine. Since, the beginning of the pandemic millions of patients worldwide have had their care delayed as hospitals canceled non-urgent operations, including some surgeries for people with heart and orthopaedic conditions.

A very large number of operations were cancelled or postponed owing to disruption caused by COVID-19. Governments had mitigated against this major burden on patients by developing recovery plans and implementing strategies to restore surgical activity safely. For Instance, according to British Journal of Surgery, an estimated 28,404,603 operations were cancelled or postponed during the peak 12 weeks of disruption due to COVID-19.

The overall 12-week cancellation rate accounted to be 72 – 3%. Although elective surgeries resumed in the UK and many other countries in mid-2020, most hospitals were functioning at considerably reduced capacity, which translates to an ever-lengthening waitlist.

As of September, 2020, nearly 140,000 patients in England alone had been waiting for more than a year for their surgeries – 100 times the number in 2019. And with a new, highly transmissible variant of SARS-CoV-2 circulating in the UK, resulting in a third national lockdown and further cancellations, patients now face even longer waits.

Furthermore, according to the National Library of Medicine, the decline in the wave was improved to 51% for ophthalmic procedures, 68% for pain procedures, and 49% for orthopedic procedures. The number of electoral processes conducted increased but was still below pre-pandemic standards. Thus, the overall COVID-19 impact on autotransfusion devices market is negative but the market is again gaining traction and expected to grow in coming years.

BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated and Zimmer Biomet are a few leading companies operating in the global autotransfusion devices market.

Key Topics Covered:

1. Introduction

1.1 Scope of the Study

1.2 Research Report Guidance

1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

4. Autotransfusion Devices Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. Autotransfusion Devices Market- Key Market Dynamics

5.1 Market Drivers

5.1.1 Rapid Increase in Chronic Diseases

5.1.2 Rise in Transplants

5.1.3 Difficulty in Obtaining Blood of Rare Groups

5.2 Market Restraints

5.2.1 Product Recalls

5.2.2 Risks Associated with Autotransfusion

5.3 Market Opportunities

5.3.1 Elevated Healthcare Expenditure in Emerging Economies

5.4 Future Trends

5.4.1 Technological Developments in Autotransfusion Devices

5.5 Impact Analysis

6. Autotransfusion Devices Market- Global Analysis

6.1 Global Autotransfusion Devices Market Revenue Forecast and Analysis

6.2 Global Autotransfusion Devices Market Revenue Forecast and Analysis

6.3 Market Positioning of Key Players

7. Autotransfusion Devices Market Analysis – By Type

7.1 Overview

7.2 Autotransfusion Devices Market Revenue Share, by Type (2021 and 2028)

7.3 Products

7.3.1 Overview

7.3.2 Products: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

7.3.3 Intraoperative Autotransfusion Systems

7.3.4 Postoperative Autotransfusion Systems

7.3.5 Dual-Mode Autotransfusion Systems

7.4 Accessories

8. Autotransfusion Devices Market Analysis – By Application

8.1 Overview

8.2 Autotransfusion Devices Market Revenue Share, by Application (2021 and 2028)

8.3 Cardiac Surgeries

8.4 Orthopedic Surgeries

8.5 Organ Transplantation

8.6 Trauma Surgery Procedures

9. Autotransfusion Devices Market Analysis – By End User

9.1 Overview

9.2 Autotransfusion Devices Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.4 Specialty Clinics

9.5 Ambulatory Surgery Centers

10. Global Autotransfusion Devices Market – Geographic Analysis

11. Impact of COVID-19 Pandemic on Global Autotransfusion Devices Market

12. Autotransfusion Devices Market-Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Autotransfusion Devices Market (%)

12.3 Organic Developments

12.4 Inorganic Developments

13. Company Profiles

  • Medtronic
  • Fresenius Se & Co. Kgaa
  • Teleflex Incorporated
  • Bd
  • Zimmer Biomet
  • Braile Biomedica
  • Haemonetics Corporation
  • Sarstedt AG and Co. Kg
  • Livanova plc
  • Redax S.P.A.

For more information about this report visit


Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900